MedTrace Logo

Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT

NCT03468374 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-03-16

No results posted yet for this study

Summary

Role of SPECT/CT in detection of sentinel lymph node in patients with breast cancer that is in early stage with small mass with no nodal or distant metastasis using radioactive material nannocolloid that can change surgical approach

Conditions

Interventions

DEVICE

lymphoscintigraphy

Nuclear Medicine diagnostic device using radioactive material

DEVICE

Single Photon Emission Tomography

Nuclear Medicine diagnostic device using fusion technique between SPECT and CT

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2019-10-31
Completion
2022-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03468374 on ClinicalTrials.gov